Quantcast
Last updated on April 18, 2014 at 15:02 EDT

Latest Profil Institute Stories

2014-02-12 08:28:24

Clinical program focused on reversing type 1 diabetes symptoms in patients diagnosed within six months of trial initiation EDGEWATER, N.J. and SAN DIEGO, Feb. 12, 2014 /PRNewswire/ -- DiaVacs, Inc., a clinical stage biotechnology company focused on developing cell-based therapy for treatment of type 1 diabetes, and Profil(® )Institute for Clinical Research, Inc., an early phase clinical research organization focused on diabetes and obesity, announced today a strategic collaboration...

2013-11-04 16:28:06

SAN DIEGO, Nov. 4, 2013 /PRNewswire/ -- Profil® Institute for Clinical Research, Inc., a company providing science-driven early phase diabetes and obesity clinical research, announced today the appointment of Dan Bradbury, Managing Member of BioBrit, LLC and former Amylin Pharmaceutical CEO, to its Board of Directors. Mr. Bradbury joins Profil Institute's current Board Directors Dr. John Amatruda, a pharmaceutical research executive and former Senior Vice President and Head of...

2013-06-04 08:26:07

Textbook provides detailed coverage of established and newly introduced Type 2 diabetes drugs, including mode of action, pharmacokinetics, efficacy, adverse effects and treatment algorithms SAN DIEGO, June 4, 2013 /PRNewswire/ -- Profil Institute for Clinical Research, Inc., a center of excellence performing early phase diabetes, obesity and cardiometabolic clinical research, announced today a new textbook Drug Therapy for Type 2 Diabetes written by the company's Senior Scientific...

2013-04-17 16:24:46

Profil Institute's 9th Year as a Corporate Sponsor of ADA's Fund-raising Event SAN DIEGO, April 17, 2013 /PRNewswire/ -- Profil® Institute for Clinical Research, Inc., focused on providing science-driven early phase diabetes, obesity and cardiometabolic clinical research services, announced today its 9(th) year as a corporate sponsor of the American Diabetes Association's Tour de Cure and a 100% increase of participants fund-raising for this event as members of the Profil...

2012-10-04 02:23:08

SAN DIEGO, Oct. 4, 2012 /PRNewswire/ -- Profil Institute for Clinical Research, Inc., a specialized clinical research institute optimizing early phase diabetes, obesity and cardiometabolic drug development, announced today that Prof. Andrew J Krentz M.D., Senior Director of Scientific Services, has been appointed Editor-in-Chief of the online journal Cardiovascular Endocrinology (www.cardiovascularendocrinology.com). The journal was officially launched this week at the European Association...

2012-06-08 14:21:31

SAN DIEGO and ORLANDO, Fla., June 8, 2012 /PRNewswire/ -- Profil® Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, and Florida Hospital, one of nation's largest clinical care providers, announced today a joint venture to establish a state-of-the-art early phase clinical services center for metabolic disease research, including diabetes, obesity and cardiometabolic diseases. The Profil Institute at Florida Hospital will...

2012-05-03 02:30:59

SAN DIEGO, May 3, 2012 /PRNewswire/ -- Profil® Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, announced today record growth in the number of clinical trials in the pipeline. Profil Institute also reports an increase in the number of mid-size biotech and off-shore clients, while maintaining active collaborations with the largest global pharmaceutical companies, driven by a strong demand for Phase I and metabolic disease...

2012-03-21 02:22:33

SAN DIEGO, March 21, 2012 /PRNewswire/ -- Profil(®) Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, announced today its continued focus on contributing to scientific research in the public domain. The company published research on new therapies in diabetes in nine scientific journals last year and one of its key scientists Prof. Andrew Krentz has authored two textbooks on drug therapy for type 2 diabetes, due to...

2012-01-31 05:30:00

SAN DIEGO, Jan. 31, 2012 /PRNewswire/ -- Profil(®) Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, announced today the appointment of Dr. John Amatruda, a pharmaceutical research executive, and Dr. Jerrold Olefsky, professor of medicine at the University of California, San Diego, to its Board of Directors. "Drs. Amatruda and Olefsky are prominent and highly respected leaders both in the global bio-pharmaceutical industry...

2011-06-16 05:30:00

SAN DIEGO, June 16, 2011 /PRNewswire/ -- Profil® Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, announced today the appointment of Dr. Andrew Krentz as Senior Director of Scientific Services. Dr. Krentz, who is currently a senior scientific consultant for Profil Institute, will take on his new position in October following his relocation from the UK to San Diego. In his new role he will oversee...